CSat Investment Advisory’s Idexx Laboratories IDXX Stock Holding History

CSat Investment Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$18K	Buy	37 +3	+9%	+$1.5K	0.02%	394
2020 Q4	$17K	Sell	34 -429	-93%	-$192K	0.02%	371
2020 Q3	$182K	Buy	463 +9	+2%	+$3.33K	0.02%	295
2020 Q2	$150K	Buy	454 +27	+6%	+$7.82K	0.02%	363
2020 Q1	$104K	Buy	427 +133	+45%	+$34.7K	0.02%	336
2019 Q4	$76K	Buy	294 +80	+37%	+$21.1K	0.02%	442
2019 Q3	$58K	Buy	214 +21	+11%	+$5.84K	0.02%	459
2019 Q2	$53K	Buy	193 +110	+133%	+$27.1K	0.02%	477
2019 Q1	$19K	Buy	83 +2	+2%	+$413	0.01%	328
2018 Q4	$15K	Buy	81 +40	+98%	+$8.2K	0.01%	348
2018 Q3	$10K	Hold	41	–	–	0.01%	367
2018 Q2	$9K	Buy	+41	New	+$8.45K	﹤0.01%	371

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSat Investment Advisory's IDXX Position: Q1 2021 in Review

CSat Investment Advisory increased its Idexx Laboratories (IDXX) stake by 8.8% in Q1 2021, buying an estimated $1.5K and bringing the position to 37 shares worth $18K. The position accounts for 0.02% of the portfolio, ranked #394.

CSat Investment Advisory first reported a position in IDXX in Q2 2018 and has held it in 12 quarters since. The position peaked at $182K in Q3 2020. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

CSat Investment Advisory held 37 shares of Idexx Laboratories worth $18K as of Q1 2021.
CSat Investment Advisory bought 3 Idexx Laboratories shares in Q1 2021, an estimated $1.5K.
Idexx Laboratories made up 0.02% of CSat Investment Advisory's portfolio in Q1 2021, its #394 holding.
CSat Investment Advisory first reported a position in Idexx Laboratories in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's Idexx Laboratories position peaked at $182K in Q3 2020.
1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.